Archive for the ‘Multiple Sclerosis’ Category
Wednesday, November 7th, 2007
The MS Society will shine the spotlight on multiple sclerosis (MS) in children this week when it brings together professionals in paediatric MS and affected families to a groundbreaking event in London on 7 November.
Awareness of MS in children - who have been known to show symptoms at just 13 ...
Posted in Multiple Sclerosis | No Comments »
Monday, October 29th, 2007
A common acne medication that has been available for over 30 years has the potential to delay the progress of multiple sclerosis and if proven effective, will offer an inexpensive option for the treatment of early MS, says the MS Society of Canada.
Clinical researchers in Calgary and 13 other Canadian ...
Posted in Multiple Sclerosis | No Comments »
Tuesday, October 16th, 2007
Genzyme Corporation (Nasdaq: GENZ) announced that top-line, three-year data from a completed Phase 2 clinical trial comparing alemtuzumab with Rebif(R) (interferon beta- 1a) for the treatment of multiple sclerosis were presented this weekend at the 23rd Congress of the European Committee for ...
Posted in Multiple Sclerosis | No Comments »
Wednesday, October 10th, 2007
Accentia Biopharmaceuticals announces that it met with the Food and Drug Administration (FDA) on September 26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune™. The FDA has indicated its support for Accentia to submit an IND for a pivotal Phase 3 randomized controlled, multi-center clinical trial of ...
Posted in Multiple Sclerosis | No Comments »
Sunday, September 23rd, 2007
UroToday.com -Presented Monday, 03 September 2007 at the 29th Congress of the Societe International d'Urologie - SIU 2007 - Optimizing Clinical Outcomes in Prostate and Renal Cell Carcinomas - The Second Annual Symposium on Advanced GU Malignancy - Palais des Congres de Paris, France
Introduction: The aim of the study was ...
Posted in Multiple Sclerosis | No Comments »
Sunday, August 26th, 2007
Until recently physicians have had to rely on time-consuming and uncertain behavioural examinations to diagnose the onset of brain diseases such as multiple sclerosis, Alzheimer's and schizophrenia.
Research published in the Institute of Physics' Journal of Neural Engineering suggests that we could soon be able to diagnose the onset of many ...
Posted in Alzheimers / Dementia, Multiple Sclerosis, Neurology / Neuroscience, Psychology / Psychiatry | No Comments »
Tuesday, August 14th, 2007
A new DNA vaccine may be helpful for those who suffer from multiple sclerosis (MS), according to an article in this week's online issue of Archives of Neurology (JAMA/Archives). The article explains that the vaccine works on the brain and immune system.
Myelin sheaths protect the nerve cells in the brain ...
Posted in Multiple Sclerosis | No Comments »
Tuesday, August 7th, 2007
In a study just published, researchers have shown for the first time that early treatment can slow the rate at which disability progresses in individuals who have had a first event suggestive of multiple sclerosis but who have not yet been diagnosed with definite MS. The study is a follow-up ...
Posted in Multiple Sclerosis | No Comments »
Monday, August 6th, 2007
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced the one-year anniversary of TYSABRI® (natalizumab) as a treatment for relapsing forms of multiple sclerosis (MS). One year following its return to market in the US and introduction in the European Union, the companies estimate that as of mid-July ...
Posted in Multiple Sclerosis | No Comments »
